SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-24-003513
Filing Date
2024-02-06
Accepted
2024-02-06 17:00:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 innatepharma-prosupp020624.htm 424B5 954443
2 EX-FILING FEES exhibit107-prosupp020624.htm EX-FILING FEES 999
3 backcoverlogo1aa.jpg GRAPHIC 31782
4 companylogoa.jpg GRAPHIC 9066
5 innatelogoa.jpg GRAPHIC 14865
6 prospectussummary1aa.jpg GRAPHIC 42031
  Complete submission text file 0001628280-24-003513.txt   1091548
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276164 | Film No.: 24601051
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)